American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection

American Journal of Gastroenterology

Volumn 108, Issue 2, 2013, Pages 177-185

  Brandt, Lawrence J ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACTINOBACTERIA; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; BACTEROIDES THETAIOTAOMICRON; BACTEROIDETES; CLOSTRIDIUM DIFFICILE INFECTION; COLON FLORA; CONSTIPATION; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FECAL MICROBIOTA TRANSPLANT; FECES MICROFLORA; FIRMICUTES; FOLLOW UP; GASTROENTEROLOGICAL PROCEDURE; GASTROINTESTINAL DISEASE; GIARDIA; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; IRRITABLE COLON; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; LISTERIOSIS; LONG TERM CARE; MICROBIOME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOBACTERIA; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ULCERATIVE COLITIS; VIBRIO CHOLERAE; VIBRIO PARAHAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENEMA; ENTEROCOCCUS FAECALIS; ENTEROCOLITIS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ESCHERICHIA COLI; FECES; HUMANS; INTESTINES; KLEBSIELLA PNEUMONIAE; METAGENOME; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84873570579     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.450     Document Type: Review

References (54)

1. Zhang F, Luo W, Shi Y et al. Should we standardize the 1700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1755.
2. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-14.
3. Sekirov I, Russell SL, Antunes CM, Finlay RB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904.
4. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial fl ora. Science 2005; 308: 1635-8. (Pubitemid 40807514)
5. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837-48. (Pubitemid 43261456)
6. Swidsinski A, Loening-Bauke V, Lochs H, Hale LP. Spatial organization of bacterial fl ora in normal and infl amed intestine: A fl uorescence in sitühybridization study in mice. World J Gastroenterol 2005; 11: 1131-40. (Pubitemid 40352998)
7. Huurre A, Kalliomaki M, Rautava S et al. Mode of delivery: Eff ects on gut microbiota and humoral immunity. Neonatology 2008; 93: 236-40. (Pubitemid 351799101)
8. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC et al. Analysis of intestinal fl ora development in breast-fed and formula-fed infants by using molecular identifi cation and detection methods. J Pediatr Gastroenterol Nutr. 2000; 30: 61-7. (Pubitemid 30349947)
9. Biasucci G, Rubini M, Riboni S et al. Mode of delivery aff ects the bacterial community in the newborn gut. Early Hum Dev 2010; 86 (Suppl 1): 13-5.
10. WüGD, Chen J, Hoff mann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
11. Stappenback TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99: 15451-5. (Pubitemid 35403955)
12. Hooper LV, Wong MH, Th elin A et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-4. (Pubitemid 32120760)
13. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-8. (Pubitemid 32440925)
14. Mazmanian SK, Lin CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-18. (Pubitemid 40977944)
15. Zeuthen LH, Fink LN, Frokiner H. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth-factor beta. Immunology 2008; 123: 197-208.
16. Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate infl ammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5: 104-12. (Pubitemid 38081475)
17. Bates JM, Akerland J, M ittge E, Guillemin K. Intestinal alkaline phosphatase detoxifi es lipopolysaccharide and prevents infl ammation in zebrafi sh in response to the gut microbiota. Cell Host Microbe 2007; 2: 371-82. (Pubitemid 350215326)
18. Corr SC, Gahan CG, Hill C. Impact of selected Lactobacillus and Bifi dobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol 2007; 50: 380-8. (Pubitemid 47041463)
19. Flint HJ. Obesity and the gut microbiota. J Clin Gastroenterol 2011; 45: S128-32.
20. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism, and personalized health care. Nat Rev Microbiol 2005; 3: 431-8. (Pubitemid 40590386)
21. Bakken JS, Borody T, Brandt LJ et al. Fecal Microbiota Transplantation (FMT) Workgroup. Treating Clostridium diffi cile infection with fecal microbiota transplantation. Clin Gastroenterol and Hepatol 2011; 9: 1044-9.
22. Eiseman B, Silen W, Bascom GS et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-9.
23. Schwan A, Sjolin S, Trottestam Üet al. Relapsing Clostridium diffi cile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983; 2: 845.
24. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium diffi cile colitis: Case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580-5. (Pubitemid 36259562)
25. Persky SE, Brandt LJ. Treatment of recurrent Clostridium diffi cile -associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 2000; 95: 3283-5.
26. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium diffi cile infection. Clin Gastroenterol Hepatol 2010; 8: 471-3.
27. Brandt LJ, Reddy S. Fecal microbiota transplantation for recurrent Clostridium diffi cile infection. J Clin Gastroenterol 2011; 45: S159-67.
28. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium diffi cile infection. Clin Infect Dis 2011; 53: 994-1002.
29. Mattila E, Uusitalo-Sepp ä l ä R, Wuorela M et al. Fecal Transplantation, through colonoscopy, is eff ective therapy for recurrent Clostridium diffi cile infection. Gastroenterology 2010; 142: 490-6.
30. Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium diffi cile infection: Report on a case series. Anaerobe; 23 November 2012 pii S1075-9964(12)00153-9; doi: 10.1016/j.anaerobe. 2012.11.004 (e-pub ahead of print).
31. Borody TJ, Warren EF, Leis SM et al. Bacteriotherapy using fecal fl ora: Toying with human motions. J Clin Gastroenterol 2004; 38: 475-83. (Pubitemid 38808419)
32. McFarland LV, Surawicz CM, Rubin M et al. Recurrent Clostridium diffi cile Disease. Epidemiology and Clinical Characteristics. Infect Contr and Hosp Epidemiol 1999; 20: 43-50.
33. Lawley TD, Clare S, Walker AW et al. Targeted restoration of the intestinal microbiota with a simple, defi ned bacteriotherapy resolves relapsing Clostridium diffi cile disease in mice. PLoS Pathog 8: E1002995; doi: 10.1371/journal.ppat.1002995.
34. Chang JY, Antonopoulos DA, Kalra A et al. Decreased diversity of the fecal microbiome in recurrent Clostridium diffi cile -associated diarrhea. J Infect Dis 2008; 197: 435-8. (Pubitemid 351263426)
35. Macfarlane GT, Macfarlane S. Fermentation in the human large intestine. Its physiologic consequences and the potential contribution of probiotics. J Clin Gastrooenterol 2011; 45: S120-7.
36. Hamilton MJ, Weingarden AR, Sadowsky MJ et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium diffi cile infection. Am J Gastroenterol 2012; 107: 761-7.
37. Brandt LJ, Aroniadis OC, Mellow M et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium diffi cile infection. Am J Gastroenterol. 2012; 107: 1079-87.
38. van Nood E, Speelman P, Kuiper EJ et al. Struggling with recurrent Clostridium diffi cile infections: Is donor faeces the solution? Euro Surveill 2009; 14: Pii:19316.
39. Brandt LJ, Borody TJ, Campbell J. Endoscopic Fecal Microbiota Transplantation: " First-Line " treatment for severe Clostridium diffi cile infection. J Clin Gastroenterol. 2011; 45: 655-7.
40. Sartour RB. Microbial infl uences in infl ammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
41. Rajiilic-Stojanovic M, Biagi E, Heilig HG et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792-801.
42. Quigley E. The enteric microbiota in the pathogenesis and management of constipation. Best Pract Res Clin Gastroenterol 2011; 25: 119-26.
43. Anathaswamy A. Faecal transplant eases symptoms of Parkinson's. New Scientist; issue 2796, 19 January 2011.
44. Borody TJ, Nowak A, Torres M et al. Bacteriotherapy in chronic fatigue syndrome: A retrospective review. Am J Gastroenterol 2012; 107 (Suppl 1) , S591-592 (A1481).
45. Borody TJ, Leis S, Campbell J et al. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS) [abstract]. Am J Gastroenterol 2011; 106: S352.
46. Borody TJ, Rosen DM, Torres M et al. Myoclonus-dystonia (M-D) mediated by GI microbiota diarrhoea treatment improves M-D symptoms. Am J Gastroenterol 2011; 106: S352.
47. Turnbaugh PJ, Ley RE, Mahowald MA et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31. (Pubitemid 46018515)
48. Vrieze A, van Nood E, Holleman F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in subjects with metabolic syndrome. Gastroenterology 2012; 143: 913-916.
49. Finegold SM, Molitors D, Song Y. Gastrointestinal micro fl ora studies in late-onset autism. Clin Infect Dis. 2002; 35: S6-16.
50. Borody TJ, Campbell J, Torres M et al. Reversal of idiopathic thrombocytopenic purpura (ITP) with fecal microbiota transplantation (FMT) [abstract]. Am J Gastroenterol 2011; 106: S352.
51. Collins SM, Bercik P. The Relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136: 2003-14.
52. Bravo JA, Forsythe P, Chew MV et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011; 108: 16050-5.
53. Bercik P, Park AJ, Sinclair D et al. The anxiolytic eff ect of Bifi dobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011; 23: 1132-9.
54. KaüAL, Ahern PP, Griff en NW et al. Human nutrition, the gut micro biome, and immune system: Envisioning the future. Nature 2011; 474: 327-36.